Literature DB >> 2449825

Puzzling persistent hyperamylasemia, probably neither pancreatic nor pathologic.

A L Warshaw1, M M Hawboldt.   

Abstract

Increased serum amylase levels most commonly signify pancreatic disease. One hundred seventeen consecutive patients were studied because their serum amylase levels were abnormally high for periods ranging from 3 to 48 weeks. In each case, extensive clinical and radiologic evaluation had failed to reveal a reason for the abnormality. The amylase isoenzymes of their sera were separated by polyacrylamide gel electrophoresis, and the fractions were measured by a saccharogenic assay. The findings in the 117 patients showed that 79 percent had non-pancreatic causes for their hyperamylasemia. The biggest single group (64 percent) had a normal distribution of isoamylases, albeit at unusually high concentrations. This phenomenon, which has not been defined previously, is probably a variant of normal in which the homeostatic balance between production and metabolism is set at a high level. Macroamylasemia accounted for 6 percent of the cases and salivary hyperamylasemia for only 9 percent. Three patients had the characteristic isoamylase pattern ("old amylase") associated with pancreatic pseudocysts. Isoamylase fractionation is a cheap, efficient, and effective means of ruling out a pancreatic cause for hyperamylasemia. It is probable that in the majority of cases of persistent hyperamylasemia without obvious clinical cause there will be no disease at all.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449825     DOI: 10.1016/s0002-9610(88)80112-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Tramadol poisoning with hyperamylasemia.

Authors:  Alaa El-Hussuna; Regnar Bøge Arnesen; Jacob Rosenberg
Journal:  BMJ Case Rep       Date:  2010-08-06

2.  Expression of the human amylase genes: recent origin of a salivary amylase promoter from an actin pseudogene.

Authors:  L C Samuelson; K Wiebauer; D L Gumucio; M H Meisler
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

3.  Clinical significance of chronic hyperamylasemia.

Authors:  M Ventrucci; R Pezzilli; D Festi
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

4.  Alpha-Amylase Activity in Blood Increases after Pharmacological, But Not Psychological, Activation of the Adrenergic System.

Authors:  Urs M Nater; Roberto La Marca; Katja Erni; Ulrike Ehlert
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.